According to LabCorp's latest financial reports the company's current EPS (TTM) is $11.07. In 2022 the company made an earnings per share (EPS) of $13.93 a decrease over its 2021 EPS that were of $24.58.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $11.07 | -20.53% |
2022 | $13.93 | -43.33% |
2021 | $24.58 | 54.11% |
2020 | $15.95 | 89.43% |
2019 | $8.42 | -3.33% |
2018 | $8.71 | -29.7% |
2017 | $12.39 | 75.74% |
2016 | $7.05 | 63.19% |
2015 | $4.32 | -28.4% |
2014 | $6.03 | -6.13% |
2013 | $6.43 | 5.2% |
2012 | $6.11 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | $8.40 | -24.12% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $8.06 | -27.19% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -$1.01 | -109.12% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $1.54 | -86.09% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | -$0.60 | -105.42% | ๐บ๐ธ USA |